Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Teen Nicotine Addiction Lawsuits Over JUUL Vape Pens Cleared To Move Forward July 28, 2021 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all federal JUUL nicotine addiction lawsuits rejected an effort by defendants to have a series of bellwether cases dismissed, allowing certain claims brought on behalf of teens who became hooked on the popular vaping pods to move forward toward a series of early “bellwether” trial dates scheduled to begin next year. JUUL Labs, Inc., Altria and other defendants currently faces more than 4,500 product liability lawsuits filed in federal courts nationwide, each raising similar allegations that JUUL vape pens were intentionally marketed toward teens and prior non-smokers, without adequately disclosing the serious health risks associated with their products, as part of a coordinated effort to create a new generation of customers with a life-long nicotine addiction. Given common questions of fact and law raised in complaints brought throughout the federal court system, the JUUL litigation is currently centralized before U.S. District Judge William H. Orrick III in the U.S. District Court for the Northern District of California, for coordinated discovery and pretrial proceedings. Learn More About JUUL and E-Cigarette Lawsuits Nicotine addiction and severe lung injuries from JUUL and vaping products have resulted in lawsuits against manufacturers of e-cigarettes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About JUUL and E-Cigarette Lawsuits Nicotine addiction and severe lung injuries from JUUL and vaping products have resulted in lawsuits against manufacturers of e-cigarettes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As part of the management of the cases, Judge Orrick has established a “bellwether” process, where a small group of personal injury cases are being prepared for early trial dates, which are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. In a court order (PDF) issued on July 22, Judge Orrick rejected a request by defendants to have the cases dismissed, although some strict product liability claims and claims involving certain state laws involving negligence were removed from the claims. One of the defendants who tried to get the cases dismissed was Altria, which purchased a significant stake in JUUL several years ago. However, Judge Orrick indicated plaintiffs had enough evidence to at least present their case to a jury over Altria’s involvement with JUUL marketing tactics. “I find that there is a sufficient connection between Altria’s acts in California and plaintiffs’ claims,” Judge Orrick ruled. “Plaintiffs identify meetings that occurred between Altria and JLI (JUUL Labs, Inc.) in California regarding the intent and eventual implementation of their business agreements and arrangements through which Altria supported JLI’s manufacturing, regulatory, marketing, and distribution efforts and how Altria’s efforts through JLI in California achieved their common goals. Those efforts and goals implemented in and emanating from California resulted in the injuries the bellwether plaintiffs allege.” The decision means the bellwether cases will continue to move forward toward potential trials over the coming months, which will be closely watched and may have a substantial influence on any JUUL settlement negotiations to resolve the teen nicotine addiction lawsuits. The Court also issued an amended case trial schedule (PDF) on July 23, scheduling a series of trials to begin on April 18, 2022, June 27, 2022, September 12, 2022 and November 7, 2022. The first case was originally expected to begin in February 2022, but the dates were delayed, as a number of other deadlines for completion of discovery in the bellwether pool cases were delayed. JUUL Teen Addiction Concerns JUUL pods were just introduced in 2015, and quickly became the most popular form of nicotine exposure among teens and young adults in the United States. Marketing efforts by the manufacturer have been blamed for fueling the teen vaping epidemic, which has caused widespread disruption in schools, additional costs for local municipalities and left young adults addicted to high levels of nicotine in each JUUL pod, often leading to smoking and long-term health concerns. The JUUL vape pens were designed to look like USB drives, allowing teens to hide their vaping habit from parents and school officials. The pods were also sold in a variety of candy-like flavors intended to appeal to prior non-smokers, and the manufacturer targeted teens through social media and other efforts that failed to disclose the high levels of nicotine, which may cause life-long addiction problems. While the outcomes of these early bellwether trials will not be binding on other claims pending in the federal court system, they will be closely watched and may greatly influence any JUUL settlements offered by the manufacturer to avoid the need for hundreds of individual trial dates to be scheduled in different U.S. District Courts nationwide in the coming years. Tags: Children, Drug Addiction, Electronic Cigarettes, Juul, Nicotine, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (Posted: 3 days ago) A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall. MORE ABOUT: CARTIVA IMPLANT LAWSUITLawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)Cartiva Implant Failure Symptoms Reported By Big Toe Surgery Patients in Lawsuits, Social Media and FDA Adverse Events (12/26/2024) Lawsuits Over Social Media Addiction Injuries Cleared To Move Forward in MDL (Posted: 4 days ago) A federal judge has rejected a motion to dismiss claims involving wrongful death and negligence raised in lawsuits over social media addiction brought by families throughout the U.S. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITGambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025)Facebook, TikTok Named in Social Media Addiction Lawsuit Brought by Native American Tribe Over Harm to Youth (01/13/2025)Online Gaming Addiction Lawsuit Alleges Roblox, Epic Games Intentionally Targeted Minors (12/20/2024) BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (Posted: 5 days ago) A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker. MORE ABOUT: BIOZORB LAWSUITSchedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications (02/04/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (Posted: 3 days ago) A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall. MORE ABOUT: CARTIVA IMPLANT LAWSUITLawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)Cartiva Implant Failure Symptoms Reported By Big Toe Surgery Patients in Lawsuits, Social Media and FDA Adverse Events (12/26/2024)
Lawsuits Over Social Media Addiction Injuries Cleared To Move Forward in MDL (Posted: 4 days ago) A federal judge has rejected a motion to dismiss claims involving wrongful death and negligence raised in lawsuits over social media addiction brought by families throughout the U.S. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITGambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025)Facebook, TikTok Named in Social Media Addiction Lawsuit Brought by Native American Tribe Over Harm to Youth (01/13/2025)Online Gaming Addiction Lawsuit Alleges Roblox, Epic Games Intentionally Targeted Minors (12/20/2024)
BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (Posted: 5 days ago) A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker. MORE ABOUT: BIOZORB LAWSUITSchedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)Joint BioZorb Marker Lawsuit Claims Implant Caused Seroma, Infections and Other Complications (02/04/2025)